- Ranbaxy Laboratories shares fall after US drug recallDr Reddy's Lab, Ranbaxy, Glenmark shares hit by worries about Russia, Ukraine salesRanbaxy Laboratories recalls some batches of generic Lipitor in latest quality blowIndian stocks to watch: Ranbaxy Laboratories, Reliance Industries, Mahindra and Mahindra and more
Shares of a href="http://www.financialexpress.com/stocks.php?EXCHNG=NSE&cocode=469" target="_blank">Ranbaxy Laboratories Ltd fell 3.8% intra-day on Monday after the drugmaker recalled the generic version of Lipitor.
Ranbaxy, a unit of Tokyo-based Daiichi Sankyo, is withdrew 64,626 bottles of atorvastatin calcium from the US market after a product complaint was received by a pharmacist, the US Food and Drug Administration said on its website. The scrip was trading 2.51% lower at Rs 361.05 at 12.00pm IST on the BSE.
Four plants of Ranbaxy — Toansa, Dewas, Paonta Sahib and Mohali — have been banned by the US FDA for deficiencies in manufacturing practices.